Remove COVID-19 Vaccine Remove Licensing Remove Public Health Remove World Health
article thumbnail

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

Research funding contracts can help to safeguard against profound inequities in global allocation and distribution of lifesaving diagnostics, drugs, and vaccines. During large transnational public health crises, global demand soars for diagnostics, drugs, and vaccines. Using Contracts to Further Equity Goals.

article thumbnail

COVID ‘Compromise’ on International IP Underscores Need for New Approach

Bill of Health

It only narrowly modifies compulsory licenses of patents covering COVID vaccines. Moreover, it imposes additional restrictions on use of compulsory licenses. Moreover, Brazil’s new compulsory license law models another critical feature that domestic laws should have – a way around data exclusivity. Third, the U.S.

COVID-19 309
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

Legally speaking, patent pledges are comparable to the open source software licenses that underlie much of the world’s technology infrastructure and the Creative Commons licenses that make billions of online images, videos and other content freely available (both discussed here ). Tesla and Toyota) to software (e.g,

article thumbnail

Reclaiming Global Public Health

Bill of Health

Fielding calls from heads of state, they decided what vaccine deliveries to prioritize , shaping which countries could protect lives and livelihoods. The answer to one of the most important public health questions of our time — who gets access to vaccines? — Private decisions did not match public health need.

article thumbnail

Biden Administration Unveils Long-Awaited COVID-19 Rules For Large Employers and Healthcare Workers

Health Law RX

An employee is considered “fully vaccinated” two weeks after completing primary vaccination with a COVID-19 vaccine with, if applicable, at least the minimum interval between doses as recommended by the CDC, World Health Organization (“WHO”), or if administered as a part of a clinical trial.